S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 05:36 PM ET

EBRCZ

EBR SYS INC.

Price Chart
Latest Quote

$0.28

+0.09 (+48.56%)
Current Price
Previous Close $0.19
Open $0.36
Day High $0.36
Day Low $0.36
Volume 77,500
Fetched: 2026-06-19T21:36:35
Stock Information
Shares Outstanding 450.56M
Total Debt $59.53M
Cash Equivalents $29.87M
Revenue $3.98M
Net Income $-55.28M
Sector Healthcare
Industry Medical Devices
Market Cap $125.23M
EPS (TTM) $-0.21
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$113.96M
Sales$3.98M
Income$-55.28M
Book/sh$0.02
Cash/sh$0.07
Employees135
Financial Ratios
Quick Ratio2.90
Current Ratio4.48
Debt/Eq624.18
Returns & Margins
ROA-42.11%
ROE-458.80%
Gross Margin16.94%
Operating Margin-684.67%
Ownership
Insider Ownership1.14%
Institutional Ownership32.76%
Insider & Institutional transactions data not available
Valuation Ratios
P/S31.47
P/B13.24
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.27
SMA50$0.39
SMA200$0.62
RSI45.86
ATR0.0231
Shares Float356.37M
Rel Volume0.08
Performance History
Week+48.56%
Month-25.28%
Quarter-39.58%
6 Months-53.96%
YTD-76.84%
Year-49.29%
3 Years-13.41%
10 Years-13.41%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $0.28 850
2026-06-17 $0.19 0
2026-06-16 $0.19 0
2026-06-15 $0.19 0
2026-06-12 $0.19 0
2026-06-11 $0.19 0
2026-06-10 $0.19 0
2026-06-09 $0.19 28,505
2026-06-08 $0.35 22,000
2026-06-05 $0.32 0
2026-06-04 $0.32 0
2026-06-03 $0.32 6,134
2026-06-02 $0.34 139,693
2026-06-01 $0.30 0
2026-05-29 $0.30 12,994
2026-05-28 $0.28 0
2026-05-27 $0.30 6,185
2026-05-26 $0.31 634
2026-05-22 $0.37 6,000
2026-05-21 $0.37 0
2026-05-20 $0.37 0
2026-05-19 $0.37 12,000
About EBR SYS INC.

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

📰 Latest News
No news articles available at the moment. Check back later for updates on EBRCZ.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Total Revenue $0 $0 - -
Operating Revenue $0 $0 - -
Expenses
Interest Expense $6,029,668 $4,483,731 $1,525,795 $19,009,916
Total Expenses $38,319,028 $34,548,947 $26,742,522 $17,185,608
Other Income Expense $370,975 $715,975 $-7,283,210 $-3,658,715
Other Non Operating Income Expenses $360,996 $718,959 $483 $2,616,902
Net Non Operating Interest Income Expense $-2,848,684 $-1,202,291 $939,127 $-18,991,046
Interest Expense Non Operating $6,029,668 $4,483,731 $1,525,795 $19,009,916
Operating Expense $38,319,028 $34,548,947 $26,742,522 $17,185,608
General And Administrative Expense $11,253,601 $7,402,921 $5,406,095 $3,139,286
Selling And Marketing Expense - $6,894,312 $8,107,645 $6,814,151
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-40,798,272 $-35,036,888 $-33,088,205 $-39,835,369
Net Interest Income $-2,848,684 $-1,202,291 $939,127 $-18,991,046
Interest Income $3,180,984 $3,281,440 $2,464,922 $18,870
Normalized Income $-40,806,155 $-35,034,531 $-27,334,469 $-33,559,752
Net Income From Continuing And Discontinued Operation $-40,798,272 $-35,036,888 $-33,088,205 $-39,835,369
Total Operating Income As Reported $-38,319,028 $-34,548,947 - -
Net Income Common Stockholders $-40,798,272 $-35,036,888 $-33,088,205 $-39,835,369
Net Income $-40,798,272 $-35,036,888 $-33,088,205 $-39,835,369
Net Income Including Noncontrolling Interests $-40,798,272 $-35,036,888 $-33,088,205 $-39,835,369
Net Income Continuous Operations $-40,798,272 $-35,036,888 $-33,088,205 $-39,835,369
Pretax Income $-40,796,737 $-35,035,263 $-33,086,605 $-39,835,369
Interest Income Non Operating $3,180,984 $3,281,440 $2,464,922 $18,870
Operating Income $-38,319,028 $-34,548,947 $-26,742,522 $-17,185,608
Special Income Charges - $-5,134,460 $-7,283,693 $-5,584,610
Depreciation Amortization Depletion Income Statement - $752,257 $652,432 $384,022
Depreciation And Amortization In Income Statement - $752,257 $652,432 $384,022
Depreciation Income Statement - $752,257 $652,432 $384,022
Per Share
Diluted EPS $-0.13 $-0.12 $-0.12 $-0.94
Basic EPS $-0.13 $-0.12 $-0.12 $-0.94
Other
Tax Effect Of Unusual Items $2,096 $-627 $-1,529,474 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-34,189,563 $-29,796,291 $-24,277,600 $-14,549,836
Total Unusual Items $9,979 $-2,984 $-7,283,210 $-6,275,617
Total Unusual Items Excluding Goodwill $9,979 $-2,984 $-7,283,210 $-6,275,617
Reconciled Depreciation $587,485 $752,257 $652,432 $384,022
EBITDA (Bullshit earnings) $-34,179,584 $-29,799,275 $-31,560,810 $-20,825,453
EBIT $-34,767,069 $-30,551,532 $-31,560,810 $-20,825,453
Diluted Average Shares $324,995,419 $291,078,900 $271,665,480 $42,443,743
Basic Average Shares $324,995,419 $291,078,900 $271,665,480 $42,443,743
Diluted NI Availto Com Stockholders $-40,798,272 $-35,036,888 - -
Tax Provision $1,535 $1,625 $1,600 $0
Gain On Sale Of Security $9,979 $-2,984 $483 $-691,007
Research And Development $27,065,427 $27,146,026 $13,228,782 $7,232,171
Selling General And Administration $11,253,601 $7,402,921 $13,513,740 $9,953,437
Other Gand A $11,253,601 $7,402,921 $5,406,095 $3,139,286
Impairment Of Capital Assets - $5,134,460 $7,283,693 $5,588,249
Gain On Sale Of Ppe - - - $3,639
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $24,355,501 $31,056,452 $43,949,093 $75,897,722
Total Assets $73,559,494 $78,898,477 $71,679,023 $85,424,068
Total Non Current Assets $9,093,111 $4,523,561 $5,093,763 $4,324,845
Other Non Current Assets $2,064,959 $589,646 $589,624 $437,660
Current Assets $64,466,383 $74,374,916 $66,585,260 $81,099,223
Other Current Assets $276,419 $382,522 $607,543 $173,882
Prepaid Assets $1,693,560 $1,446,634 $2,004,441 $1,716,878
Inventory $1,391,008 $0 - -
Receivables $441,439 $230,734 $443,919 $966,123
Receivables Adjustments Allowances $0 $-142,166 $-101,681 $-110,914
Other Receivables $441,439 $372,900 $265,143 $843,879
Cash Cash Equivalents And Short Term Investments $60,663,957 $72,315,026 $63,529,357 $78,242,340
Cash And Cash Equivalents $6,917,546 $14,578,752 $15,456,338 $78,242,340
Cash Equivalents $3,706,990 $13,603,442 - -
Cash Financial $3,210,556 $975,310 $15,456,338 $78,242,340
Accounts Receivable - $94,962 $178,776 $122,244
Allowance For Doubtful Accounts Receivable - $-142,166 $-101,681 $-110,914
Gross Accounts Receivable - $237,128 $280,457 $233,158
Debt
Net Debt $33,383,345 $25,089,431 $3,991,473 -
Total Debt $41,398,193 $41,589,289 $21,585,734 $4,807,211
Long Term Debt And Capital Lease Obligation $40,838,382 $41,316,917 $21,317,327 $2,211,008
Long Term Debt $40,263,605 $39,646,687 $19,396,221 $73,085
Current Debt And Capital Lease Obligation $559,811 $272,372 $268,407 $2,596,203
Current Debt $37,286 $21,496 $51,590 $2,410,496
Other Current Borrowings $37,286 $21,496 - -
Liabilities
Total Liabilities Net Minority Interest $49,203,993 $47,842,025 $27,729,930 $9,526,346
Total Non Current Liabilities Net Minority Interest $40,875,999 $41,393,863 $21,799,775 $2,211,008
Other Non Current Liabilities $37,617 $76,946 $482,448 -
Current Liabilities $8,327,994 $6,448,162 $5,930,155 $7,315,338
Payables And Accrued Expenses $7,768,183 $6,175,790 $2,092,474 $1,710,855
Interest Payable $224,889 $224,309 - -
Payables $3,247,453 $1,856,134 $2,092,474 $1,710,855
Accounts Payable $3,247,453 $1,856,134 $2,092,474 $1,710,855
Other Current Liabilities - $4,319,656 $3,569,274 $3,008,280
Current Notes Payable - $21,496 $51,590 $2,410,496
Equity
Common Stock Equity $24,355,501 $31,056,452 $43,949,093 $75,897,722
Total Equity Gross Minority Interest $24,355,501 $31,056,452 $43,949,093 $75,897,722
Stockholders Equity $24,355,501 $31,056,452 $43,949,093 $75,897,722
Gains Losses Not Affecting Retained Earnings $873,497 $963,277 - -
Other Equity Adjustments $873,497 $963,277 - -
Retained Earnings $-353,457,680 $-312,659,408 $-276,827,680 $-243,507,507
Other
Ordinary Shares Number $371,076,200 $309,362,697 $272,817,486 $270,029,519
Share Issued $371,076,200 $309,362,697 $272,817,486 $270,029,519
Tangible Book Value $24,355,501 $31,056,452 $43,949,093 $75,897,722
Invested Capital $64,656,392 $70,724,635 $63,396,904 $78,381,303
Working Capital $56,138,389 $67,926,754 $60,655,105 $73,783,885
Capital Lease Obligations $1,097,302 $1,921,106 $2,137,923 $2,323,630
Total Capitalization $64,619,106 $70,703,139 $63,345,314 $75,970,807
Additional Paid In Capital $376,902,576 $342,721,880 - -
Capital Stock $37,108 $30,703 $320,776,773 $319,405,229
Common Stock $37,108 $30,703 $320,776,773 $319,405,229
Long Term Capital Lease Obligation $574,777 $1,670,230 $1,921,106 $2,137,923
Current Capital Lease Obligation $522,525 $250,876 $216,817 $185,707
Current Accrued Expenses $4,520,730 $4,319,656 - -
Investments And Advances $5,303,950 $1,125,554 $985,957 -
Other Investments $5,303,950 $1,125,554 $985,957 -
Net PPE $1,724,202 $2,808,361 $3,518,182 $3,887,185
Accumulated Depreciation $-3,727,429 $-3,144,979 $-2,392,513 $-1,742,828
Gross PPE $5,451,631 $5,953,340 $5,910,695 $5,630,013
Leases $513,727 $499,148 $415,590 $415,590
Other Properties $4,363,124 $4,879,412 $2,513,318 $2,621,166
Machinery Furniture Equipment $574,780 $574,780 $2,981,787 $2,439,709
Properties $0 $0 $0 $0
Other Short Term Investments $53,746,411 $57,736,274 $48,073,019 -
Construction In Progress - - - $153,548
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-41,503,257 $-33,051,568 $-31,086,097 $-23,061,403
Operating Activities
Operating Cash Flow $-41,229,820 $-32,697,514 - -
Cash Flow From Continuing Operating Activities $-41,229,820 $-32,697,514 - -
Cash Flowsfromusedin Operating Activities Direct - $-32,697,514 $-30,355,918 $-22,149,394
Other Cash Paymentsfrom Operating Activities - $-32,697,514 $-30,355,918 $-22,149,394
Classesof Cash Receiptsfrom Operating Activities - $-32,697,514 $-30,355,918 $-22,149,394
Other Cash Receiptsfrom Operating Activities - $-32,697,514 $-30,355,918 $-22,149,394
Investing Activities
Capital Expenditure $-273,437 $-354,054 $-730,179 $-912,009
Investing Cash Flow $1,113,229 $-8,640,990 $-49,347,810 $-906,809
Cash Flow From Continuing Investing Activities $1,113,229 $-8,640,990 $-49,347,810 $-906,809
Financing Activities
Issuance Of Capital Stock $34,021,550 $21,615,076 $421,594 $80,928,636
Financing Cash Flow $32,484,046 $40,465,924 $17,013,951 $95,757,395
Cash Flow From Continuing Financing Activities $32,484,046 $40,465,924 $17,013,951 $95,757,395
Net Other Financing Charges $-2,060,823 $-1,204,024 $-1,007,643 $-5,191,496
Net Common Stock Issuance $34,021,550 $21,615,076 $421,594 $80,928,636
Common Stock Issuance $34,021,550 $21,615,076 $421,594 $80,928,636
Repurchase Of Capital Stock - $54,872 $-213,326 $-4,901,583
Other
Repayment Of Debt $-44,743 $0 $-2,400,000 $-2,404,299
Issuance Of Debt $82,029 $20,000,000 $20,000,000 $22,424,554
Interest Paid Supplemental Data $5,412,170 $3,881,400 - -
Income Tax Paid Supplemental Data $1,625 $775 - -
End Cash Position $6,917,546 $14,578,752 $15,456,338 $78,242,340
Beginning Cash Position $14,578,752 $15,456,338 $78,242,340 $5,878,281
Effect Of Exchange Rate Changes $-28,661 $-5,006 $-96,225 $-337,133
Changes In Cash $-7,632,545 $-872,580 $-62,689,777 $72,701,192
Proceeds From Stock Option Exercised $486,033 $54,872 - -
Net Issuance Payments Of Debt $37,286 $20,000,000 $17,600,000 $20,020,255
Net Long Term Debt Issuance $37,286 $20,000,000 $17,600,000 $20,020,255
Long Term Debt Payments $-44,743 $0 $-2,400,000 $-2,404,299
Long Term Debt Issuance $82,029 $20,000,000 $20,000,000 $22,424,554
Net Investment Purchase And Sale $1,386,666 $-8,286,936 $-48,617,631 -
Sale Of Investment $66,901,676 $69,174,324 $2,000,000 -
Purchase Of Investment $-65,515,010 $-77,461,260 $-50,617,631 -
Net PPE Purchase And Sale $-273,437 $-354,054 $-730,179 $-906,809
Purchase Of PPE $-273,437 $-354,054 $-730,179 $-912,009
Change In Working Capital $-2,141,791 $696,048 - -
Change In Other Current Liabilities $-413,007 $-408,786 - -
Change In Other Current Assets $57,253 $206,424 - -
Change In Payables And Accrued Expense $1,519,057 $255,430 - -
Change In Accrued Expense $171,316 $341,777 - -
Change In Interest Payable $580 $126,294 - -
Change In Payable $1,347,741 $-86,347 - -
Change In Account Payable $1,347,741 $-86,347 - -
Change In Prepaid Assets $-247,712 $556,143 - -
Change In Inventory $-2,842,540 $0 - -
Change In Receivables $-214,842 $86,837 - -
Changes In Account Receivables $-214,842 $86,837 - -
Other Non Cash Items $-624,041 $-455,227 - -
Stock Based Compensation $1,742,279 $1,305,811 - -
Provisionand Write Offof Assets $4,520 $40,485 - -
Depreciation Amortization Depletion $587,485 $752,257 - -
Depreciation And Amortization $587,485 $752,257 - -
Depreciation $587,485 $752,257 - -
Net Income From Continuing Operations $-40,798,272 $-35,036,888 - -
Common Stock Payments - $54,872 $-213,326 $-4,901,583
Classesof Cash Payments - $-32,697,514 $-30,355,918 $-22,149,394
Sale Of PPE - - - $5,200
Fetched: 2026-02-02